PATENT CLAIM ANALYSIS

Application Number: 16205871
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["424", "133100"]

Abstract:
Methods of treating a patient, such as a patient with breast cancer, and methods of selecting a therapy for a patient. The methods of treating a patient may include determining one or more expression levels for a set of biomarkers from a biological sample of the patient. The biological sample may include breast cancer tissue.

Claim (Index 3):
The method of  claim 2 , wherein the set of biomarkers further comprises at least one of lymphocyte-specific protein tyrosine kinase (LCK) or estrogen receptor-1 (ESR1).

Metadata:
- Claim Count in Document: 13.0
- Percentile: 98.0
- Lexical Diversity: 1.81818
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11787044', '13957720', '15019829', '12282029', '13245706']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6727653326643173
- 35 USC 102 Novelty (BERT): 0.5206289651598414
- Combined Prediction Score: 0.6575516959138697
- Mean Citation Score: 211.711128
- Max Citation Score: 224.85518
- Similarity Product: 125.6789579338336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test